ESC 365 - The CNP analogue vosoritide reduces arrhythmia in diabetic cardiomyopathy via cGMP-dependent PDE2 stimulation on cellular and organ level

ESC Premium Access

The CNP analogue vosoritide reduces arrhythmia in diabetic cardiomyopathy via cGMP-dependent PDE2 stimulation on cellular and organ level

Session: Novel mechanisms of arrhythmogenic cardiac disease

Topic: Arrhythmias

Speaker: Ms R. Firneburg (Dresden, DE)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Ms Rebecca Firneburg

Faculty of Medicine Carl Gustav Carus TU Dresden, Dresden (Germany)

0 follower

5 more presentations in this session

Serum exosomal long non-coding RNA H19 as a theragnostic target for atrial fibrillation

Speaker: Ms J. Kang (Seoul, KR)

Investigating the role of an orphan nuclear receptor NR4A1 in atrial fibrillation

Speaker: Mr C. Yiu (Oxford, GB)

Role of common variants and new genes associated with arrhythmogenic cardiomyopathy

Speaker: Doctor J. barc (Nantes, FR)

Characterization of knock-in zebrafish models with a novel SLC4A3 variant identified in a short QT syndrome family

Speaker: Ms M. Zhu (Suita, JP)

The H222P-Lamin mutation induces heart failure via impaired mitochondrial calcium uptake in human cardiac laminopathy

Speaker: Professor J. Hulot (Paris, FR)

Access the full session

Novel mechanisms of arrhythmogenic cardiac disease

Speakers: Ms R. Firneburg, Ms J. Kang, Mr C. Yiu, Doctor J. barc, Ms M. Zhu...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources